Deciphera Pharmaceuticals (DCPH) Misses Q4 EPS by 18c

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q4 EPS of ($1.51), $0.18 worse than the analyst estimate of ($1.33). Revenue for the quarter came in at $24.2 million versus the consensus estimate of $23.29 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

You May Also Be Interested In

• Intel (INTC) Misses Q1 EPS by 24c; misses on guidance
• Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
• Southern Copper Corp. (SCCO) Tops Q1 EPS by 20c